BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8326393)

  • 1. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
    Harris EW; Rakow JI; Weiner M; Agress H
    J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers?
    Israel O; Front D
    J Nucl Med; 1993 Aug; 34(8):1330-2. PubMed ID: 8326394
    [No Abstract]   [Full Text] [Related]  

  • 3. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
    Burns DE; Schiffman FJ
    Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
    Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
    Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal Hodgkin disease in children: response to therapy.
    Luker GD; Siegel MJ
    Radiology; 1993 Dec; 189(3):737-40. PubMed ID: 8234698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.
    Small EJ; Venook AP; Damon LE
    Cancer; 1993 Aug; 72(3):905-8. PubMed ID: 8334644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin disease: use of Tl-201 to monitor mediastinal involvement after treatment.
    Fletcher BD; Xiong X; Kauffman WM; Kaste SC; Hudson MM
    Radiology; 1998 Nov; 209(2):471-5. PubMed ID: 9807576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium-67 uptake in a mass of benign transformation mimicking recurrence of nodular lymphocytic predominance Hodgkin's disease.
    Bar-Shalom R; Ben-Arie Y; Gaitini D; Epelbaum R; Parmett S; Israel O; Front D
    J Nucl Med; 1994 Mar; 35(3):465-8. PubMed ID: 8113898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
    Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis of thymic hyperplasia and mediastinal tumor in patients with lymphogranulomatosis after chemotherapy].
    Moiseeva TN; Al'-Radi LS; Shitareva IV; Shevelev AA; Kostina IE; Kravchenko SK; Kremenetskaia AM; Tsyba NN
    Ter Arkh; 2011; 83(7):47-50. PubMed ID: 21894751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma.
    Peylan-Ramu N; Haddy TB; Jones E; Horvath K; Adde MA; Magrath IT
    J Clin Oncol; 1989 Dec; 7(12):1800-6. PubMed ID: 2585021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive gallium-67 and thallium-201 scans in thymic rebound after chemotherapy for lymphoma.
    Akaki S; Shinya T; Sato S; Kuroda M; Kanazawa S
    Ann Nucl Med; 2006 Feb; 20(2):161-3. PubMed ID: 16615427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
    Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
    Howman-Giles R; Uren RF; Shaw PJ
    J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
    Edington H; Salwitz J; Longo DL; Roth JA; Pass H
    J Surg Oncol; 1986 Oct; 33(2):120-3. PubMed ID: 3762184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simulation of a mediastinal non-Hodgkin lymphoma recurrence by a diffuse thymus hyperplasia in 18F-FDG PET scan].
    Glatz S; Kotzerke J; Moog F; Sandherr M; Heimpel H; Reske SN
    Rofo; 1996 Sep; 165(3):309-10. PubMed ID: 8924697
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge.
    Feldges A; Wagner HP; Bubeck B; Kehrer B; Ries G; Schmid U; Waibel P
    Pediatr Surg Int; 1997; 12(8):613-7. PubMed ID: 9354739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium 67 uptake in thymic rebound.
    Hurst R; Sabio H; Teates CD
    South Med J; 1988 Sep; 81(9):1167-9. PubMed ID: 3420448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
    Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
    J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.